HCPCS code K0730: Controlled dose inhalation billing guide

Key takeaways

HCPCS code K0730 describes a controlled dose inhalation drug delivery system, not a wheelchair or mobility item.

Medicare Part B covers K0730 for one use only: delivering iloprost (Q4074) to a beneficiary with pulmonary hypertension.

Only five ICD-10-CM codes support medical necessity for K0730, and they sit in Group 14 of Policy Article A52466.

Every K0730 claim line needs a KX, GA, or GZ modifier, or the DME MAC rejects it as missing information.

Practice management software like Pabau helps billing teams track K0730 orders, refill timing, and documentation dates in one place.

HCPCS code K0730 describes a controlled dose inhalation drug delivery system. Medicare Part B covers it for a single purpose. That purpose is delivering iloprost (Q4074) to a beneficiary who has pulmonary hypertension. Used with any other inhalation solution, the claim is denied as not reasonable and necessary.

The code is also easy to misfile. It sits in the miscellaneous durable medical equipment range K0669–K0746, near the power wheelchair codes. Coders sometimes treat it as mobility equipment, and it is not a mobility code.

This guide covers the official descriptor, the coverage criteria in Nebulizers LCD L33370, and the five ICD-10 codes that support medical necessity. It also covers the modifier rules, the documentation package, and the denial patterns that follow K0730.

HCPCS code K0730: Definition and code details

K0730 is a HCPCS Level II code maintained by the Centers for Medicare and Medicaid Services (CMS). K-codes are assigned to durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) items that no permanent code describes. CMS added K0730 on July 1, 2005, and the descriptor has not been revised since.

How a controlled dose inhalation drug delivery system works

Policy Article A52466 describes the device in two sentences. Aerosol is delivered in pulses during inspiration, and the duration of each pulse adapts to the patient’s breathing pattern. That pulsed, breath-actuated delivery is what separates K0730 from a standard jet nebulizer. A jet nebulizer runs continuously and loses drug on every exhalation.

Dose control matters here because of the drug. Iloprost is inhaled in microgram doses, six to nine times a day during waking hours. A delivery system that cannot meter each dose reliably is not clinically equivalent, which is why CMS created a separate code for it.

Medicare coverage criteria for HCPCS code K0730

Medicare covers K0730 only when it is reasonable and necessary to administer iloprost (Q4074) to a beneficiary with pulmonary hypertension. The Nebulizers LCD (L33370) states this in a single line and allows no other indication. Claims for K0730 used with any other inhalation solution are denied as not reasonable and necessary.

Coverage of the device is bound to coverage of the drug. If iloprost fails the criteria below, the DME MAC denies K0730 with it. Reviewing the device criteria on their own will not tell you whether a claim is payable.

The iloprost coverage criteria in full

Iloprost (Q4074) is considered for coverage when all three of the following criteria are met.

1. Diagnosis of pulmonary artery hypertension: The beneficiary carries a diagnosis from the Group 14 code list in Policy Article A52466.
2. Not secondary to excluded causes: The pulmonary hypertension is not secondary to pulmonary venous hypertension, such as left-sided atrial, ventricular, or valvular disease. It also must not be secondary to a disorder of the respiratory system, such as COPD, interstitial lung disease, or sleep-disordered breathing.
3. Primary disease, or a listed secondary cause plus four sub-criteria: The beneficiary has primary pulmonary hypertension. Alternatively, the hypertension is secondary to connective tissue disease, HIV infection, cirrhosis, anorexigens, or congenital left-to-right shunts.

Where one of those secondary causes applies, the record must also show all four of the following.

• The pulmonary hypertension has progressed despite maximal medical or surgical treatment of the identified condition.
• The mean pulmonary artery pressure is greater than 25 mm Hg at rest, or greater than 30 mm Hg with exertion.
• The beneficiary has significant symptoms, meaning severe dyspnea on exertion plus fatigability, angina, or syncope.
• Oral calcium channel blocking agents have been tried and failed, or were considered and ruled out.

The second criterion drives most medical necessity denials. Pulmonary hypertension caused by left heart disease or by lung disease is common, and it is exactly what the LCD excludes. The referring physician’s note has to show which type of pulmonary hypertension the beneficiary has, not simply that pressures are elevated.

ICD-10 codes that support medical necessity for K0730

Policy Article A52466 lists exactly five ICD-10-CM codes for K0730 and Q4074, grouped together as Group 14. A diagnosis outside this list will not support the claim, however well the clinical narrative reads.

Two nearby codes are deliberately absent. I27.23, pulmonary hypertension due to lung diseases and hypoxia, describes the respiratory-system cause that criterion two rules out.

I27.24, chronic thromboembolic pulmonary hypertension, is not among the secondary causes the LCD names for iloprost. Both sit in the same I27 block, which our ICD-10-CM code library lists in full.

Group 14 is also newer than many billing templates. Before June 5, 2022, K0730 and Q4074 shared a diagnosis group with other nebulizer drugs. If your code set was built before that revision and has not been refreshed, it may still carry diagnoses the DME MAC no longer accepts.

Medicare reimbursement for K0730

K0730 is a capped rental item. CMS assigns it pricing indicator 36, capped rental DME subject to floors and ceilings, and type of service R, rental of durable medical equipment. Suppliers bill it monthly rather than as a one-time purchase.

Capped rental runs for a maximum of 13 months of continuous use. Ownership then transfers to the beneficiary, and the supplier stops billing rental months. Each rental claim carries the RR modifier plus the rental-month modifier that matches its position in the sequence. The map below shows which modifier belongs to which month.

Allowed amounts vary by state and are updated at least annually, so a fixed dollar figure goes stale quickly. Look up the current amount in the CMS DMEPOS fee schedule for your jurisdiction. Medicare pays 80% of the allowed amount after the Part B deductible, and the beneficiary or a secondary payer covers the remaining 20%.

The drug is paid separately from the device. Iloprost billed under Q4074 is priced through the Part B average sales price methodology, not the DMEPOS fee schedule. A denial on the device does not automatically reverse payment on the drug. In practice the DME MAC denies both together when coverage criteria fail.

K0730 billing guidelines

K0730 is billed on a DMEPOS claim to the DME MAC for the beneficiary’s jurisdiction, not to the local Part B carrier. Work through the sequence below before each batch goes out.

1. Confirm the drug is iloprost: K0730 is payable only when it delivers Q4074. Any other inhalation solution makes the device claim not reasonable and necessary.
2. Check the diagnosis against Group 14: Use one of the five ICD-10-CM codes listed above, and confirm the medical record supports it.
3. Apply a coverage modifier: Add KX when every criterion is met. Use GA or GZ when they are not, depending on whether you hold a valid Advance Beneficiary Notice.
4. Add the rental modifiers: Append RR to each monthly claim, with KH, KI, or KJ to identify the rental month.
5. Bill one unit per rental month: K0730 represents one delivery system. A second unit on the same month will not pay.
6. Bill the drug on its own line: Q4074 is submitted separately, with its own KX, GA, or GZ modifier matching the device line.

A mismatch between the two lines is a common and avoidable error. If the device line carries KX and the drug line carries GZ, the contractor sees a supplier attesting and not attesting to the same criteria.

Modifiers used with K0730

One rule catches more claims than any other. A K0730 or Q4074 claim line submitted without KX, GA, or GZ is rejected as missing information, not denied on medical necessity. A rejection does not carry appeal rights, so the line has to be corrected and resubmitted.

The unit dose modifiers behave differently here. KO, KP, and KQ apply to inhalation drug codes rather than to the device, and the policy article specifically excludes Q4074 from the KO modifier. A Q4074 line billed with KP or KQ is rejected as invalid for claim submission.

Documentation requirements for K0730

The file has to prove two points at once. The beneficiary needs iloprost, and the beneficiary needs this device to take it. Build the supporting documentation package around the items below.

• Standard Written Order (SWO): Carries the beneficiary’s name or Medicare Beneficiary Identifier, the order date, and a general description of the item. It also carries the quantity to be dispensed and the treating practitioner’s name or NPI and signature.
• Drug order detail: For a drug supplied with a DME item, the order names the drug and its concentration. It can instead give administration instructions with the amount and frequency, plus the number of refills.
• Medical record support: Notes showing the beneficiary was evaluated or treated for pulmonary hypertension and needs K0730 to deliver iloprost.
• Evidence for each coverage criterion: The record shows the type of pulmonary hypertension, the mean pulmonary artery pressure, and the symptom picture. It also shows the calcium channel blocker trial, or the reason it was ruled out.
• Proof of delivery: A signed delivery slip, itemized sales receipt, or shipping documentation that identifies the item, quantity, and delivery date.
• Refill documentation: The beneficiary gives an affirmative response, obtained no sooner than 30 days before the current supply runs out. Shipment follows no sooner than 10 days before that date.
• Continued medical need: The supplier verifies this within 12 months of the date of service. A recent order, a change in order, or timely documentation of use will do it.

Keep the drug order on file even when your company supplies only the device. The nebulizer drug policy does not require it, but auditors ask for the Standard Written Order for the drug when they review the device. Suppliers who cannot produce it lose the claim.

Retain the full record for at least seven years from the date of service, in line with the DMEPOS supplier standards. A structured compliance workflow makes expiring orders and overdue continued-need checks visible before they turn into denials.

Accessories billed with K0730

LCD L33370 pairs K0730 with a single accessory code. That code is A7005, an administration set with a small volume nonfiltered pneumatic nebulizer, non-disposable. Any other compressor and accessory combination is treated as not reasonable and necessary.

The replacement frequency is where supply revenue quietly leaks. A7005 is normally allowed once every six months. Used with K0730, the usual maximum rises to once every three months. Billing the six-month frequency on a K0730 patient leaves payable supply claims unbilled. Our full guide to A7005 covers the rest of that code’s rules.

Related HCPCS codes

K0730 rarely appears on a claim by itself. The codes below are the ones it is billed with, mistaken for, or compared against.

K0730 is not a power wheelchair code

This is worth stating plainly, because third-party code lists get it wrong. K0730 has nothing to do with wheelchairs, joysticks, or drive controls. No HCPCS code carries the descriptor “controlled power module”, and the phrase appears in no CMS policy.

Power wheelchair bases live in the range K0813 to K0899. Drive control interfaces are E-codes, including E2312 for a mini-proportional remote joystick and E2373 for a compact remote joystick. K0740, the code nearest to K0730, covers repair labor on oxygen equipment and is unrelated to both.

Common claim denial reasons for HCPCS code K0730

K0730 denials cluster around a short, predictable list. Mapping each remittance message to a fix beats reworking claims one at a time.

• Missing coverage modifier: The line was submitted without KX, GA, or GZ and rejected as missing information. Add the modifier rule to the K0730 and Q4074 code templates so it cannot be skipped.
• Device used with another drug: K0730 was billed while the beneficiary received an inhalation solution other than iloprost. Confirm the dispensed drug before the device line is created.
• Diagnosis outside Group 14: The claim carried a pulmonary hypertension code that the policy article does not list, such as I27.23. Refresh your stored diagnosis set against the current policy article.
• Excluded cause of hypertension: The record shows hypertension secondary to left heart disease or lung disease. Ask the referring physician to document the type before delivery, not after a denial.
• Missing calcium channel blocker history: The note omits whether calcium channel blockers were tried, failed, or ruled out. Add that item to the intake checklist for every iloprost referral.
• Missing refill or continued-need documentation: The refill contact fell outside the 30-day window, or continued medical need was not verified within 12 months. Both are calendar problems, so schedule them rather than tracking them by hand.

A structured denial management workflow sorts these by cause and routes each one to the team that can fix it. Documentation denials go back to intake, and modifier rejections go back to the claim template.

How Pabau supports accurate K0730 billing

Most K0730 problems are calendar problems in disguise. A refill contact made a day too early, a continued-need check that slipped past 12 months, an A7005 supply line billed on the wrong interval. Teams working from spreadsheets and inbox reminders catch these late, usually when the remittance arrives.

Pabau, our practice management software, keeps the clinical record, the order, and the billing timeline in one place. Coverage evidence for each criterion lives on the patient record where the biller can see it. Recurring tasks handle the refill window and the annual continued-need check, so nobody is tracking dates in a side file.

The result is a shorter path from referral to paid claim. Your team spends its time on the criteria that genuinely need a clinical judgment, instead of chasing documentation that should have been filed at intake.

Tired of chasing DME documentation after the denial?

Pabau keeps orders, coverage evidence, refill dates, and billing on one record, so your team submits clean K0730 and Q4074 claims the first time. See how it fits your workflow.

Book a demo

Conclusion

K0730 rewards a supplier who front-loads the work. Almost every failure on this code is decided at intake, when the referral is accepted and the record is assembled.

Once the type of pulmonary hypertension, the drug, and the calcium channel blocker history are on file, the monthly claims are close to mechanical. Get that file wrong and resubmission will not save it, because a missing coverage modifier is a rejection with no appeal rights.

The trade-off worth remembering is volume. K0730 is a low-volume code, so it rarely earns a dedicated process. That is exactly why it fails. A three-month supply interval and a 13-month rental clock do not survive manual tracking.

Pabau’s audit-ready claims management keeps the order, the coverage evidence, and the refill dates on one record. To see how it fits your billing workflow, book a demo.

Continue your research

Want to cut rework on DMEPOS denials? Denial management in healthcare explains how to categorize, appeal, and prevent repeat denial patterns.

Need to tighten your audit readiness? Medical billing compliance outlines the documentation and retention standards that apply to DMEPOS suppliers.

Building the claim itself? Key components of a clean claim covers the fields a payer checks before a line is ever adjudicated.

Decoding a K0730 remittance? Denial codes in medical billing maps the common remark codes to the fix each one needs.

Frequently asked questions